724. Human Papillomavirus (HPV) Vaccine Uptake Rate in Comparison to Meningitis and TdaP Booster Vaccines in a University Based Outpatient Clinic.
Session: Poster Abstract Session: Vaccines: Adolescent HPV and Meningococcal
Thursday, October 27, 2016
Room: Poster Hall
Background: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and a known cause for cervical cancer. There are approximately 14 million new genital HPV infections in the United States yearly with an estimated 50% occurring in 15 to 24 year olds.  The quadrivalent HPV Vaccine and the recently introduced 9 strain HPV vaccine cover the HPV strains which are responsible for most cases of cervical cancer and genital warts. Ten years have passed since the advent of the quadrivalent vaccine, but acceptance rates compared to other routine childhood vaccinations still remains low. This is especially true for adolescent males compared to females. This study examines the acceptance rates of the HPV vaccine in adolescent males and females compared to the meningitis and Tdap booster vaccines.

Methods: A retrospective chart review was conducted on all adolescents seen at a university based outpatient clinic between January 2013 to January 2015. Males and Females aged 11-18 years who were seen for well child or vaccine only visits were included in this study. Charts were examined for comparing the acceptance rates of the HPV vaccine with the Tdap booster and Menactra vaccines.

Results: We identified a total of 203 patients between 11-18 years in the period from January 2013 to January 2015 with 77 (38%) being female and 126 (62%) being male. Out of 77 female patients 24 (31%) refused the HPV vaccine and out of 126 male patient 70 (56%) refused the HPV vaccine. Only 7 (3%) of 203 patients refused both the Tdap and Menactra vaccines. Of these 7 patients 5 (71%) were female and 2 (29%) were male. The 7 patients who refused the Menactra and Tdap vaccines also refused the HPV vaccine.

Conclusion: The acceptance rate of the HPV vaccine in adolescent males and females compared to the meningitis and Tdap booster vaccines continues to be low. Prospective studies should address the implementation of an effective program to increase the acceptance rate of HPV vaccination by educational strategies aimed at involving parents and their children supported by general pediatricians and public health professionals.

Hillary Raab, MD, Rutgers- Robert Wood Johnson Medical School, New Brunswick, NJ, Emanuel Lerner, MD, Pediarics, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ and Aparna Arun, MD, Pediatrics, Rutgers- Robert Wood Johnson Medical School, New Brunswick, NJ

Disclosures:

H. Raab, None

E. Lerner, None

A. Arun, None

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.